Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging

J Control Release. 2016 Dec 10:243:303-322. doi: 10.1016/j.jconrel.2016.10.023. Epub 2016 Oct 26.

Abstract

Recently, a great interest has been paid to the development of hybrid protein-inorganic nanoparticles (NPs) for drug delivery and cancer diagnostics in order to combine the merits of both inorganic and protein nanocarriers. This review primarily discusses the most outstanding advances in the applications of the hybrids of naturally-occurring proteins with iron oxide, gadolinium, gold, silica, calcium phosphate NPs, carbon nanotubes, and quantum dots in drug delivery and cancer imaging. Various strategies that have been utilized for the preparation of protein-functionalized inorganic NPs and the mechanisms involved in the drug loading process are discussed. How can the protein functionalization overcome the limitations of colloidal stability, poor dispersibility and toxicity associated with inorganic NPs is also investigated. Moreover, issues relating to the influence of protein hybridization on the cellular uptake, tumor targeting efficiency, systemic circulation, mucosal penetration and skin permeation of inorganic NPs are highlighted. A special emphasis is devoted to the novel approaches utilizing the protein-inorganic nanohybrids in combined cancer therapy, tumor imaging, and theranostic applications as well as stimuli-responsive drug release from the nanohybrids.

Keywords: Anti-cancer drug delivery; Cancer imaging; Inorganic nanoparticles; Nanohybrids; Protein nanoparticles; Theranostics; Tumor targeting.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Diagnostic Imaging / methods
  • Drug Carriers / chemistry
  • Drug Delivery Systems*
  • Humans
  • Nanoparticles*
  • Neoplasms / diagnostic imaging
  • Neoplasms / drug therapy
  • Proteins / administration & dosage*
  • Proteins / chemistry
  • Theranostic Nanomedicine / methods

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Proteins